(Q35612304)

9 August 2017

1 reference

title

The insulin-like growth factor system in advanced breast cancer (English)

1 reference

9 August 2017

1 reference

Svein Inge Helle

1

1 reference

9 August 2017

publication date

1 March 2004

1 reference

Best Practice and Research: Clinical Endocrinology and Metabolism

9 August 2017

published in

1 reference

9 August 2017

volume

18

1 reference

9 August 2017

issue

1

1 reference

9 August 2017

page(s)

67-79

1 reference

Circulating concentrations of insulin-like growth factor I and risk of breast cancer

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

The role of the IGF system in cancer: from basic to clinical studies and clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

The IGF system and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Recovery of growth hormone release from suppression by exogenous insulin-like growth factor I (IGF-I): evidence for a suppressive action of free rather than bound IGF-I.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

New concepts in regulation and function of the insulin-like growth factors: implications for understanding normal growth and neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Regulation of embryonic growth and lysosomal targeting by the imprinted Igf2/Mpr gene

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Interactions of cathepsin-D and insulin-like growth factor-II (IGF-II) on the IGF-II/mannose-6-phosphate receptor in human breast cancer cells and possible consequences on mitogenic activity of IGF-II

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Type-2 IGF receptor: a multi-ligand binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Insulin-like growth factor (IGF)-I rescues breast cancer cells from chemotherapy-induced cell death--proliferative and anti-apoptotic effects

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Analysis of insulin-like growth factor I gene expression in malignancy: evidence for a paracrine role in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Demonstration of insulin-like growth factor (IGF-I and -II) receptors and binding protein in human breast cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Insulin-like growth factor-I receptor signaling and resistance to trastuzumab (Herceptin).

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Tyrosine kinase signalling in breast cancer: insulin-like growth factors and their receptors in breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Processing of insulin-like growth factor-II (IGF-II) by human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Regulation of insulin-like growth factor-binding-protein-1, 2, 3, 4, 5, and 6: synthesis, secretion, and gene expression in estrogen receptor-negative human breast carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Insulin-Like Growth Factor Binding Protein Secretion by Breast Carcinoma Cell Lines: Correlation with Estrogen Receptor Status*

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Role of insulin-like growth factor binding protein-3 in breast cancer cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Insulin-like growth factor 1 and oestradiol promote cell proliferation of MCF-7 breast cancer cells: new insights into their synergistic effects

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Insulin receptor substrate 1 is a target for the pure antiestrogen ICI 182,780 in breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Activation of estrogen receptor-mediated gene transcription by IGF-I in human breast cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Role of insulin-like growth factor-I in regulating estrogen receptor-alpha gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Insulin-like growth factor-1 receptors and insulin-like growth factor-1-like activity in human primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Insulin-like growth factor 1 receptors in human breast tumour: localisation and quantification by histo-autoradiographic analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Analysis of the IGF-II receptor gene copy number in breast carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Loss of heterozygosity at the mannose 6-phosphate insulin-like growth factor 2 receptor gene correlates with poor differentiation in early breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Interference of the IGF system as a strategy to inhibit breast cancer growth

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Treatment of human breast cancer cells with antisense RNA to the type I insulin-like growth factor receptor inhibits cell growth, suppresses tumorigenesis, alters the metastatic potential, and prolongs survival in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Stromal IGF-II messenger RNA in breast cancer: relationship with progesterone receptor expressed by malignant epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Loss of imprinting of IGF2 and not H19 in breast cancer, adjacent normal tissue and derived fibroblast cultures

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Detection of insulin-like growth factor binding proteins (IGFBPs) by ligand blotting in breast cancer tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

The prognostic value of insulin-like growth factor-I in breast cancer patients. Results of a follow-up study on 126 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Down-regulation of insulin-like growth factor-I receptor and insulin receptor substrate-1 expression in advanced human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Correlation of Insulin-Like Growth Factor-Binding Protein-3 Messenger RNA With Protein Expression in Primary Breast Cancer Tissues: Detection of Higher Levels in Tumors With Poor Prognostic Features

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Insulin-like growth factor-binding protein-3 and breast cancer survival

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Serum levels of insulin-like growth factor-I in operable breast cancer in relation to the main prognostic variables and their perioperative changes in relation to those of prolactin

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Altered serum levels of insulin-like growth-factor binding proteins in breast cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Insulin-like growth-factor-binding protein 3 is decreased in early-stage operable pre-menopausal breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Plasma insulin-like growth factor binding protein-3 proteolysis is increased in primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Influence of treatment with tamoxifen and change in tumor burden on the IGF-system in breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Insulin-like growth factor binding protein (IGFBP) proteases: functional regulators of cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Endogenous IGFBP-3 is protected from inducible IGFBP-3 protease activity in normal adult serum

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Plasma insulin-like growth factor in primary breast cancer patients treated with adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Effects of oral and transdermal oestrogen replacement therapy on plasma levels of insulin-like growth factors and IGF binding proteins 1 and 3: a cross-over study.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Effect of tamoxifen on serum insulinlike growth factor I levels in stage I breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Effect of acute and chronic administration of tamoxifen on GH response to GHRH and on IGF-I serum levels in women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Alterations in the insulin-like growth factor system during treatment with diethylstilboestrol in patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Effect of long-term estrogen deprivation on apoptotic responses of breast cancer cells to 17beta-estradiol

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

The aromatase inhibitor letrozole in advanced breast cancer: Effects on serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 levels

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

The effect of endocrine therapy with medroxyprogesterone acetate, 4-hydroxyandrostenedione or tamoxifen on plasma concentrations of insulin-like growth factor (IGF)-I, IGF-II and IGFBP-1 in women with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Effects of treatment with megestrol acetate on the insulin-like growth factor system: time and dose dependency

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Influence of treatment with onapristone on the IGF-system in breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Treatment of metastatic breast cancer patients with different dosages of megestrol acetate; dose relations, metabolic and endocrine effects.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

The effects of dexamethasone treatment on immunoreactive and bioactive insulin-like growth factors (IGFs) and IGF-binding proteins in normal male volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Microencapsulated octreotide pamoate in advanced gastrointestinal and pancreatic cancer: a phase I study

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

Feasibility, endocrine and anti-tumour effects of a triple endocrine therapy with tamoxifen, a somatostatin analogue and an antiprolactin in post-menopausal metastatic breast cancer: a randomized study with long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

A randomized, multicenter prospective trial assessing long-acting release octreotide pamoate plus tamoxifen as a first line therapy for advanced breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900045-9

7 January 2021

10.1016/S1521-690X(03)00045-9

Identifiers

DOI

1 reference

9 August 2017

1 reference